DK2968159T3 - Behandling af osteoporose med hmw peg - Google Patents

Behandling af osteoporose med hmw peg Download PDF

Info

Publication number
DK2968159T3
DK2968159T3 DK14764671.5T DK14764671T DK2968159T3 DK 2968159 T3 DK2968159 T3 DK 2968159T3 DK 14764671 T DK14764671 T DK 14764671T DK 2968159 T3 DK2968159 T3 DK 2968159T3
Authority
DK
Denmark
Prior art keywords
osteoporosis
treatment
hmw peg
hmw
peg
Prior art date
Application number
DK14764671.5T
Other languages
Danish (da)
English (en)
Inventor
Rifat Pamukcu
Laura Rae Mccabe
Original Assignee
Midway Pharmaceuticals Inc
Univ Michigan State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Midway Pharmaceuticals Inc, Univ Michigan State filed Critical Midway Pharmaceuticals Inc
Application granted granted Critical
Publication of DK2968159T3 publication Critical patent/DK2968159T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK14764671.5T 2013-03-15 2014-03-14 Behandling af osteoporose med hmw peg DK2968159T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361798481P 2013-03-15 2013-03-15
PCT/US2014/028832 WO2014144425A1 (en) 2013-03-15 2014-03-14 Managing osteoporosis with hmw peg

Publications (1)

Publication Number Publication Date
DK2968159T3 true DK2968159T3 (da) 2019-08-12

Family

ID=51537706

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14764671.5T DK2968159T3 (da) 2013-03-15 2014-03-14 Behandling af osteoporose med hmw peg

Country Status (11)

Country Link
US (2) US10045949B2 (enExample)
EP (1) EP2968159B1 (enExample)
JP (3) JP6275239B2 (enExample)
AU (2) AU2014229082C1 (enExample)
CY (1) CY1122568T1 (enExample)
DK (1) DK2968159T3 (enExample)
ES (1) ES2744828T3 (enExample)
HU (1) HUE045032T2 (enExample)
PL (1) PL2968159T3 (enExample)
PT (1) PT2968159T (enExample)
WO (1) WO2014144425A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111419823B (zh) * 2020-04-30 2022-03-29 上海公谊药业有限公司 一种延胡索酸泰妙菌素肠溶微丸及其制备方法和用途
NL1044084B1 (nl) 2021-07-05 2023-01-11 Evers Agro B V Mestinjecteur

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10338646A (ja) * 1996-08-26 1998-12-22 Takeda Chem Ind Ltd 骨形成促進医薬組成物
ATE544354T1 (de) * 2002-11-26 2012-02-15 Univ Chicago Vermeidung und behandlung von mikrobenübertragenen epithelerkrankungen
JPWO2004105825A1 (ja) * 2003-01-10 2006-07-20 多木化学株式会社 骨形成用生体材料、該材料を含む注入用製剤、及び該材料を調製するためのキット、並びにこれらを用いる骨形成方法
JP2007533755A (ja) * 2004-04-20 2007-11-22 ザ ユニヴァーシティ オヴ シカゴ 高分子量peg様化合物を含む治療薬送達システム
US8840933B2 (en) 2006-05-03 2014-09-23 Warsaw Orthopedic, Inc. Method of treating neuronal injury by administering magnesium chloride and PEG
US9675696B2 (en) * 2006-11-14 2017-06-13 Warsaw Orthopedic, Inc. Method and use for increasing efficacy of anti-adhesive compositions in controlling inflammation and pain
US8153112B2 (en) 2007-08-03 2012-04-10 Warsaw Orthopedic, Inc. Compositions and methods for treating cavity conditions
MX2011009988A (es) * 2009-03-23 2011-11-18 Univ Chicago Metodos para la prevencion y el tratamiento de trastornos epiteliales inducidos por radiaciones.
EP2468265A3 (en) * 2010-12-04 2013-01-02 DEEF Pharmaceutical Industries Co. Homogeneous preparations containing vitamin D

Also Published As

Publication number Publication date
EP2968159A1 (en) 2016-01-20
EP2968159B1 (en) 2019-06-12
CY1122568T1 (el) 2021-01-27
JP2016513738A (ja) 2016-05-16
JP6275239B2 (ja) 2018-02-07
US20160000730A1 (en) 2016-01-07
AU2014229082A1 (en) 2015-11-05
AU2018250501A1 (en) 2018-11-15
HUE045032T2 (hu) 2019-12-30
JP2017082009A (ja) 2017-05-18
JP6619849B2 (ja) 2019-12-11
AU2014229082C1 (en) 2019-01-17
JP2018162328A (ja) 2018-10-18
ES2744828T3 (es) 2020-02-26
US10045949B2 (en) 2018-08-14
AU2018250501B2 (en) 2020-06-25
PT2968159T (pt) 2019-10-01
AU2014229082B2 (en) 2018-07-19
US20190015353A1 (en) 2019-01-17
PL2968159T3 (pl) 2019-11-29
WO2014144425A1 (en) 2014-09-18
EP2968159A4 (en) 2016-09-28

Similar Documents

Publication Publication Date Title
FIC20240023I1 (fi) Vadadustaatti
DK2968208T3 (da) Behandling af kataplexi
DK3021838T3 (da) Behandling af fedme
DK2981255T3 (da) Terapeutiske anvendelser af empagliflozin
DK3851537T3 (da) Behandling af hyperbilirubinæmi
DK3302565T3 (da) Faste doseringsformer af palbociclib
DK2984166T3 (da) Sammensætninger til behandling af mpsi
DK3137169T3 (da) Hæmmere af lysin-specifik demethylase-1
DK2970954T3 (da) Modifikation af polypeptider
DK3611262T3 (da) Fremgangsmåder til sekvensering af immunrepertoire
DK2961388T3 (da) Kombinationer af lægemidler
DK3080100T3 (da) Hæmmere af lysinspecifik demethylase-1
DK3244948T3 (da) Bestemmelse af medikamentdosis
DK3087183T3 (da) Modulation af angiopoietin-3-lignende ekspression
DK2961766T3 (da) Kvantificering af vaccinesammensætninger
DK2968221T3 (da) Farmaceutisk sammensætning af s-ketaminhydrochlorid
DK3076976T3 (da) Fremgangsmåder til behandling af cancer
DK3626270T3 (da) Behandling af kardiovaskulære sygdomme
EP2958994A4 (en) Vaccine composition
DK2965026T3 (da) Generering af slushice
PT2953948T (pt) Antagonistas de integrina fluorada
DK2961378T3 (da) Fremgangsmåder til behandlingen af mitochondrisk sygdom
LT3007726T (lt) Tautopatijos gydymo būdai
DK3511004T3 (da) Kombineret præparat til behandling af cancer
DK3024519T3 (da) Destruktion af hypodermiske kanyler